×
For best experience we recommend to activate Javascript in your browser.
14-3-3 sigma/SFN antibody (Internal Region)
This Rabbit Polyclonal antibody specifically detects 14-3-3 sigma/SFN in WB and ELISA. It exhibits reactivity toward Human.
Quick Overview for 14-3-3 sigma/SFN antibody (Internal Region) (ABIN2359171)
Target
See all 14-3-3 sigma/SFN (SFN) Antibodies
14-3-3 sigma/SFN (SFN)
(Stratifin (SFN))
Reactivity
All reactivities for 14-3-3 sigma/SFN antibodies
Human
Host
All hosts for 14-3-3 sigma/SFN antibodies
Rabbit
Clonality
All clonalities for 14-3-3 sigma/SFN antibodies
Polyclonal
Conjugate
All conjugates for 14-3-3 sigma/SFN antibodies
This 14-3-3 sigma/SFN antibody is un-conjugated
Application
All applications for 14-3-3 sigma/SFN antibodies
Western Blotting (WB), ELISA
Product Details anti-14-3-3 sigma/SFN Antibody
(hide)
Binding Specificity
All epitopes for 14-3-3 sigma/SFN antibodies
AA 119-149, Internal Region
Cross-Reactivity
Human
Cross-Reactivity (Details)
Calculated cross reactivity: Hu
Characteristics
SFN, ID (SFN, HME1, 14-3-3 protein sigma, Epithelial cell marker protein 1, Stratifin)
Purification
Purified by Protein A affinity chromatography.
Immunogen
SFN antibody is generated from rabbits immunized with a KLH conjugated synthetic between 119-149 amino acids selected from the Central region of human SFN.
Isotype
IgG
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working conditions should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Buffer
Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
-20 °C
Storage Comment
-20°C
Target Details for 14-3-3 sigma/SFN
(hide)
Target
14-3-3 sigma/SFN (SFN)
(Stratifin (SFN))
Alternative Name
SFN
NCBI Accession
NP_006133
UniProt
P31947
Pathways
p53 Signaling , Myometrial Relaxation and Contraction
Recently viewed
(hide)
Chat with us , powered by LiveChat